EMA — authorised 20 September 2017
- Marketing authorisation holder: Roche Registration GmbH
- Status: approved
🇪🇺 Tecentriq in European Union
EMA authorised Tecentriq on 20 September 2017
Marketing authorisation
Tecentriq in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Tecentriq approved in European Union?
Yes. EMA authorised it on 20 September 2017.
Who is the marketing authorisation holder for Tecentriq in European Union?
Roche Registration GmbH holds the EU marketing authorisation.